Juvenile Spondyloarthritis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2008-01-17
Clinical Trial Update: Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies [Phase 2, Phase 3]
This update reports that infliximab was studied for efficacy, safety, and tolerability in juvenile spondyloarthritis in a Phase 2/3 trial th…